UBS Group’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43M | Sell |
102,933
-356,734
| -78% | -$8.4M | ﹤0.01% | 3664 |
|
|
2025
Q1 | $11M | Buy |
459,667
+362,364
| +372% | +$8.7M | ﹤0.01% | 2265 |
|
|
2024
Q4 | $4.11M | Buy |
97,303
+14,929
| +18% | +$631K | ﹤0.01% | 3156 |
|
|
2024
Q3 | $3.64M | Buy |
82,374
+7,912
| +11% | +$350K | ﹤0.01% | 2535 |
|
|
2024
Q2 | $2.69M | Sell |
74,462
-51,921
| -41% | -$1.88M | ﹤0.01% | 2586 |
|
|
2024
Q1 | $5.45M | Buy |
126,383
+10,961
| +9% | +$473K | ﹤0.01% | 2112 |
|
|
2023
Q4 | $1.78M | Buy |
115,422
+71,487
| +163% | +$1.1M | ﹤0.01% | 2969 |
|
|
2023
Q3 | $602K | Buy |
43,935
+23,202
| +112% | +$318K | ﹤0.01% | 3478 |
|
|
2023
Q2 | $333K | Buy |
20,733
+11,800
| +132% | +$189K | ﹤0.01% | 4129 |
|
|
2023
Q1 | $69.3K | Buy |
8,933
+8,036
| +896% | +$62.4K | ﹤0.01% | 5115 |
|
|
2022
Q4 | $17.4K | Sell |
897
-4,401
| -83% | -$85.2K | ﹤0.01% | 6657 |
|
|
2022
Q3 | $113K | Buy |
5,298
+4,903
| +1,241% | +$105K | ﹤0.01% | 4564 |
|
|
2022
Q2 | $5K | Sell |
395
-1,614
| -80% | -$20.4K | ﹤0.01% | 7900 |
|
|
2022
Q1 | $47K | Buy |
+2,009
| New | +$47K | ﹤0.01% | 5541 |
|
|
2021
Q3 | – | Sell |
-956
| Closed | -$13K | – | 8807 |
|
|
2021
Q2 | $13K | Buy |
+956
| New | +$13K | ﹤0.01% | 6709 |
|